BioCryst Pharmaceuticals, Inc. (BCRX) was a big mover last session, as the company shares rose over 12% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend for the company, as the stock is now trading above the volatile price range of $9.78 to $12.42 in the past one-month time frame.
In the last 30 days, the company has not seen any estimate revision and its Zacks Consensus Estimate also remained unchanged. Friday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
BioCryst Pharmaceuticals currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.
Other better-ranked stocks in the med-drugs industry include Sagent Pharmaceuticals, Inc. (SGNT), Hyperion Therapeutics, Inc. (HPTX) and Lannett Company, Inc. (LCI). All three sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment